Ingevity Corporation · NYSE:NGVT

Ingevity — Q1 2021 Earnings Presentation

18 slides from Ingevity's earnings presentation, Apr 29, 2021

  1. Slide 1: First Quarter 2021 Earnings Presentation

    First Quarter 2021 Earnings Presentation April 29, 2021

  2. Slide 2: Disclaimer

    Disclaimer: This presentation contains “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words “will,” “plans,” “intends,” “targets,” “expects,” “outlook,

  3. Slide 3: Today's Agenda

    Today’s Agenda 1. First Quarter Highlights 2. Segment Performance 3. Financial Review 4. Revised Guidance 5. Q&A 3

  4. Slide 4: First Quarter 2021 Results

    First Quarter Q1 Q1 vs Prior Year $ in millions 2021 Results Net Sales 2021 320.3 2020 288.2 32.1 % 11.1% % Adj. EBITDA(1) 105.4 92.2 13.2 14.3% Performance Highlights Adj. EBITDA(1) 32.9% 32.0% +90 bps  Demand improvement across all businesses Margin and product lines  Sales up 11% on volume and

  5. Slide 5: Performance Chemicals

    Performance Q1 Q1 vs Prior Year $ in millions Chemicals Net Sales 2021 179.6 2020 167.1 12.5 % 7.5% % Pavement Technologies 21.4 20.7 0.7 3.4% Performance Highlights Industrial Specialties 112.1 110.1 2.0 1.8% Engineered Polymers 46.1 36.3 9.8 27.0%  Revenue of $180 million; up 7.5% Segment EBITDA

  6. Slide 6: Performance Materials

    Performance Q1 Q1 vs Prior Year $ in millions Materials Net Sales 2021 140.7 2020 121.1 19.6 % 16.2% % Segment EBITDA 73.7 61.2 12.5 20.4% Performance Highlights Segment EBITDA 52.4% 50.5% +190 bps Margin  Revenues of $141 million; up 16%  Strong automotive production and sales in China supported

  7. Slide 7: GreenGasUSA Holdings, LLC

    GreenGasUSA Holdings, LLC Strategic partnership About GreenGas From waste to clean, low-carbon RNG  Integrated renewable natural gas (RNG) solutions provider  Collects and treats biogas at contracted facilities and then sells as pipeline-quality RNG  Provides compression, transportation and deliv

  8. Slide 8: First Quarter 2021 Financial Summary

    First Quarter 2021 Financial Summary Capital Structure Working Capital Management $ in millions $ in millions Current Pricing Amount $500m Revolver L+125 $0.0 Term Loan L+150 342.2 Inventory, net $204 $189 $166mm Interest Rate Swap (1) 1.98% Senior Notes 3.875% & 4.5% 850.0 Accounts receivable, net

  9. Slide 9: 2021 Revised Guidance

    2021 Revised Guidance ($M) Q1 Revised % FY21 Item FY20 Actual Initial FY21 Guidance Guidance Revenue $1,216.1 $1,250 to $1,300 $1,275 to $1,325 Adjusted EBITDA(1) $397.9 $400 to $420 $410 to $430 Capital expenditures $82.1 $100 – 120 $100 – 120 Free Cash Flow(1) $270.3 >$200 >$200 Net Debt Ratio(1)

  10. Slide 10: For More Information

    For More Information Investors Bill Hamilton (843) 740-2138 Media Amy Chiconas (843) 746-8197 Thank you for your interest in Ingevity. 10

  11. Slide 11: Appendix

    Appendix 11

  12. Slide 12: First Quarter 2021 Financial Results

    First Quarter 2021 Financial Results vs PY $ in millions except EPS 1Q 2021 1Q 2020 ∆% Consolidated Income Statement: Net sales $320.3 $288.2 11.1% Gross Profit $126.2 $114.6 10.1% % Margin 39.4% 39.8% -40 bps Core SG&A (Non-GAAP) (1) $29.2 $28.4 2.8% Depreciation and amortization 10.8 10.1 6.9% Tot

  13. Slide 13: Non-GAAP Financial Measures

    Non-GAAP Financial Measures Ingevity has presented certain financial measures, defined below, which have not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has provided a reconciliation to the most directly comparable financial measure calculated in accor

  14. Slide 14: Reconciliation to Adjusted Earnings

    Reconciliation of Net Income (Loss) (GAAP) to Adjusted Earnings (Loss) (Non-GAAP) Three Months Ended March 31, In millions, except per data (unaudited) 2021 2020 Net income (loss) (GAAP) $ 48.7 $ 45.3 Restructuring and other (income) charges (1) 3.9 0.5 Acquisition and other related costs (2) 0.3 1.

  15. Slide 15: Reconciliation to Adjusted EBITDA

    Reconciliation of Net Income (Loss) (GAAP) to Adjusted EBITDA (Non-GAAP) Three Months Ended March 31, In millions, except percentages (unaudited) 2021 2020 Net income (loss) (GAAP) $ 48.7 $ 45.3 Provision (benefit) for income taxes 13.1 9.9 Interest expense, net 12.4 10.9 Depreciation and amortizati

  16. Slide 16: Debt Ratio Calculation

    Calculation of Total Debt to Net Income (Loss) Ratio (GAAP) to Net Debt to Adjusted EBITDA Ratio (Non-GAAP) In millions, except ratios (unaudited) March 31, 2021 Notes payable and current maturities of long-term debt $ 19.5 Long-term debt including finance lease obligations 1,263.1 Debt issuance cos

  17. Slide 17: Historical Net Debt Ratio

    Calculation of Historical Net Debt Ratio (Non-GAAP) 2017 2018 In millions, except ratios (unaudited) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net Debt(1) $ 405.1 $ 370.2 $ 314.0 $ 295.8 $ 628.7 $ 600.2 $ 627.5 $ 610.2 Adjusted EBITDA(2) 50.2 67.2 72.7 52.6 67.1 89.4 90.7 73.3 Pine Chemical Pro Forma (3) 6.0 5.6 7.5

  18. Slide 18: SG&A and Segment EBITDA Reconciliation

    Reconciliation of Selling, General and Admin (SG&A) (GAAP) to Core SG&A (Non-GAAP) Three Months Ended March 31, In millions, except percentages (unaudited) 2021 2020 SG&A (GAAP) $ 40.0 $ 38.5 Depreciation and amortization 10.8 10.1 Core SG&A (Non-GAAP) $ 29.2 $ 28.4 Net sales $ 320.3 $ 288.2 SG&A as

Ingevity — Q1 2021 Earnings Presentation on 6ix